Dr Simran Kaur
Dr Simran Kaur
Details
Role
Team Leader / Senior Research Officer
Research area
Genomic Medicine
Group
Brain and Mitochondrial
Dr. Simran Kaur, is Team Leader / Senior Research Officer for the Brain and Mitochondrial group at MCRI.
Simran is leading Australia’s first KAND (KIF1A-Associated Neurological Disorder) research program in collaboration with national and international collaborators to accelerate research into KAND. The team hopes that by better understanding disease pathophysiology, they can identify disease biomarkers and new therapies, driven by cutting-edge stem cell technology.
These advances will improve long-term health outcomes for this vulnerable group of children and may potentially offer unprecedented and life-changing opportunities for individuals and families affected by KAND.
Simran is leading Australia’s first KAND (KIF1A-Associated Neurological Disorder) research program in collaboration with national and international collaborators to accelerate research into KAND. The team hopes that by better understanding disease pathophysiology, they can identify disease biomarkers and new therapies, driven by cutting-edge stem cell technology.
These advances will improve long-term health outcomes for this vulnerable group of children and may potentially offer unprecedented and life-changing opportunities for individuals and families affected by KAND.
Dr. Simran Kaur, is Team Leader / Senior Research Officer for the Brain and Mitochondrial group at MCRI.
Simran is leading Australia’s first KAND (KIF1A-Associated Neurological Disorder) research program in collaboration with national and...
Simran is leading Australia’s first KAND (KIF1A-Associated Neurological Disorder) research program in collaboration with national and...
Dr. Simran Kaur, is Team Leader / Senior Research Officer for the Brain and Mitochondrial group at MCRI.
Simran is leading Australia’s first KAND (KIF1A-Associated Neurological Disorder) research program in collaboration with national and international collaborators to accelerate research into KAND. The team hopes that by better understanding disease pathophysiology, they can identify disease biomarkers and new therapies, driven by cutting-edge stem cell technology.
These advances will improve long-term health outcomes for this vulnerable group of children and may potentially offer unprecedented and life-changing opportunities for individuals and families affected by KAND.
Simran is leading Australia’s first KAND (KIF1A-Associated Neurological Disorder) research program in collaboration with national and international collaborators to accelerate research into KAND. The team hopes that by better understanding disease pathophysiology, they can identify disease biomarkers and new therapies, driven by cutting-edge stem cell technology.
These advances will improve long-term health outcomes for this vulnerable group of children and may potentially offer unprecedented and life-changing opportunities for individuals and families affected by KAND.
Top Publications
- Lin, Q, Sikora, T, Gao, K, Lau, R, Christodoulou, J, Gold, WA, Kaur, S. Generation, heterozygous repair and characterization of human iPSC lines from two individuals with KIF1A-Associated Neurological Disorder.. Stem Cell Res 94: 104025 2026 view publication
- Miwa-Dale, K, Norman, K, Dawson-McClaren, B, Harris, J, Gold, WA, Do, TT, Kaur, S. "I felt like a lone ranger": experiences of Australian families living with KIF1A-Associated Neurological Disorder.. J Community Genet 17(3) : 2026 view publication
- Boyle, L, Rao, L, Kaur, S, Fan, X, Mebane, C, Hamm, L, Thornton, A, Ahrendsen, JT, Anderson, MP, Christodoulou, J, et al. Genotype and defects in microtubule-based motility correlate with clinical severity in KIF1A Associated Neurological Disorder. 2026 view publication
- Kaur, S, Christodoulou, J. MECP2 Disorders. 2026 view publication
- Morison, LD, Vogel, AP, Christodoulou, J, Gold, WA, Verden, D, Chung, WK, Braden, R, Bredebusch, J, Kaur, S, Scheffer, IE, et al. Understanding speech and language in KIF1A-associated neurological disorder.. Eur J Hum Genet 34(1) : 78 -89 2026 view publication
Page 1 of 8
Career information
Share //
